BrandMemo | manage and share brands you love  Pharmamedix su Facebook  Pharmamedix su Twitter
 Home | News | About us | Comitato scientifico | Iscriviti | Utenti | Etica | Contenuti | Guida | Faq | Stage | Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Melatonina

Circadin

Bibliografia - Quali fonti bibliografiche per Melatonina?


         

1. Acuna-Castroviejo D. et al., J. Pineal. Res., 2006, 40 (1), 98.

2. Arendt J., J. Biol. Rhythms, 2005, 20, 291.

3. Belforte N.A. et al., J. Pineal Res., 2010, 48 (4), 353.

4. Bendz L.M., Scates A.C., Ann. Pharmacother., 2010, 44 (1), 185.

5. Braam W. et al., J. Child Neurol., 2008, 23 (6), 649.

6. Bregani E.R. et al., Recenti Prog. Med., 1995, 86, 231.

7. Buscemi N. et al., BMJ, 2006, 332 (7538), 385.

8. Campas F.L. et al., Am. J. Respir. Crit. Care Med., 2004, 170 (9), 947.

9. Carrillo-Vico et al., Curr. Opin. Invest. Drugs, 2006, 7, 423.

10. Chahbouni M. et al., J. Pineal Res., 2010, 48 (3), 282.

11. Chazot G. et al., Cephalalgia, 1984, 4, 13.

12. Claustrat B. et al., Cephalalgia, 1997, 17, 511.

13. Cuzzocrea S., Reiter R.J., Curr. Top. Med. Chem., 2002, 2, 153.

14. Danel T., Touitou Y., Alcohol Alcohol, 2006, 41 (4), 386.

15. Dispersyn G. et al., Anesthesiology, 2010, 112 (2), 333.

16. Fan L.L. et al., World J. Gastroenterol., 2010, 16 (12), 1473.

17. Fanciullacci M. et al., Funct. Neurol., 2000, 15 (Suppl. 3), 171.

18. Fischer T.W. et al., Br. J. Dermatol., 2004, 150 (2), 341.

19. Garde E. et al., Photochem. Photobiol., 1994, 60 (5), 475.

20. Gehrman P.R. et al., Am. J. Geriatr. Psychiatry, 2009, 17 (2), 166.

21. Gillum J.G. et al., Clin. Pharmacokinet., 1993, 25 (6), 450.

22. Guardiola-Lemaître B., J. Biol. Rhythms., 1997, 12 (6), 697.

23. Herxheimer A., Petrick K.I., Cochrane Database Syst. Rev., 2002, (2), CD001520.

24. Hhartter S. et al., Clin. Pharmacol. Ther., 2000, 67, 1.

25. Hilli J. et al., J. Clin. Pharmacol., 2008, 48 (8), 986.

26. Holliman B.J., Chyka P.A., South. Med. J., 1997, 90 (4), 451.

27. Jahnke G. et al., Toxicol. Sci., 1999, 50 (2), 271.

28. J. Allergy Clin. Immunol., 2003.

29. Kennaway D.J., Rowe S., J. Reprod. & Fertil., 1995, 49 (Suppl.), 423.

30. Klupínska G. et al., J. Clin. Gastroenterol., 2007, 41 (3), 270.

31. Leone M. et al., Cephalalgia, 1996, 16, 494.

32. Leone M. et al., Cephalalgia, 1995, 15, 224.

33. Lissoni P. et al., Eur. J. Cancer Clin. Oncol., 1989, 25, 789.

34. Lissoni P. et al., Acta Oncol., 1990, 11, 41.

35. Lissoni P. et al., Oncology, 1992, 49, 336.

36. Lissoni P. et al., Br. J. Cancer, 1992a, 66, 155.

37. Lissoni P. et al., Eur. J. Cancer, 1993b, 67, 1404.

38. Lissoni P. et al., Tumori, 1993, 79, 401.

39. Lissoni P. et al., Eur. J. Cancer, 1993, 29A, 185.

40. Lissoni P. et al., Br. J. Cancer, 1994, 69, 196.

41. Lissoni P. et al., Oncology, 1994a, 51, 344.

42. Lissoni P. et al., Cancer, 1994b, 73, 699.

43. Lissoni P. et al., Br. J. Cancer, 1995, 71, 854.

44. Lusardi P. et al., Br. J. Clin. Pharmacol., 2000, 49, 423.

45. Lissoni P., Pathol. Biol. (Paris)., 2007, 55 (3-4), 201.

46. Lissoni P. et al., Eur. Urol., 1997, 31 (2), 178.

47. Lissoni P. et al., J. Pineal Res., 2001, 30 (2), 123.

48. Ma X. et al., Drug Metab. Dispos., 2005, 33 (4), 489.

49. Maestroni G.J., Expert Opin. Investig. Drugs, 2001, 10 (3), 467.

50. Martindale, The complete drug reference, 32 ed., Pharmaceutical Press.

51. Mohammad A., Pahlavani Ph. D., Drugs of Today, 1997, 33, 25.

52. Murder H. et al., Diabetologia, 2009, 52 (7), 1240.

53. Nagtegaal J.E. et al., Headache, 1998, 38, 303.

54. Naguib M., Samarkandi A.H., Anesth. Analg., 2000, 91 (2), 473.

55. Nair N.V. et al., Biol. Psychiatriy, 1986, 21, 141.

56. Neri B. et al., Cancer, 1994, 73, 3015.

57. Ordine dei Farmacisti, “Jet-lag” consultabile on line all’indirizzo: http://www.fofi.it/cont/6470via/0807/2203/

58. Orishiki M. et al., Int. J. Biochem., 1994, 26 (6), 751.

59. Otmani S. et al., Hum. Psychopharmacol., 2008, 23 (8), 693.

60. Peres M.F., Einstein, 2005, 2, 217.

61. Peres M.F., Cephalalgia, 2005a, 25, 403.

62. Peres M.F. et al., J. Neurol. Neurosurg. Psychiatry, 2001, 71, 747.

63. Peres M.F. et al., Lancet, 2000, 355, 147.

64. Peres M.F. et al., Neurology, 2004, 63, 757.

65. Peres M.F., Rozen T.D., Caphalalgia, 2001, 21, 993.

66. Pirodda A. et al., Med. Hypotheses, 2010, 75 (2), 190.

67. Pittalis S. et al., Recenti Prog. Med., 1997, 88, 401.

68. Potenza M.N. et al., J. Pharmacol. Exp. Ther., 1999, 291, 482.

69. Rodella L.F. et al., J. Pineal Res., 2010, 48 (2), 126.

70. Rupp T.L. et al., Chronobiol. Int., 2007, 24 (3), 463.

71. Sajith S.G., Clark C.D., J. Intellect. Disabil. Res., 2007, 51 (Pt 1), 2.

72. Shamir E. et al., Arch. Gen. Psychiatry., 2001, 58 (11), 1049.

73. Scheda Prodotto Circadin.

74. Scheer F., Czeisler C.A., Sleep Med. Rev., 2005, 9, 5.

75. Schmitz M.M. et al., Prog. Neuropsychopharmacol. Biol. Psychiatry., 20 (6), 983.

76. Sheldon S.H., Lancet, 1998, 351, 1254.

77. Short R.V., Br. Med. J., 1993, 307, 952.

78. Song G.H. et al., Gut, 2005, 54 (10), 1402.

79. Stevens R.G. et al., Epidemiology, 2000, 11 (6), 660.

80. Suresh Kumar P.N. et al., J. Clin. Psychiatry., 2007, 68 (2), 237.

81. Swaab D.F. et al., Brain Res., 1985, 342, 37.

82. Todisco M., Am. J. Ther., 2006, 13 (1), 84.

83. Turek F.W. et al., Arch. Neurol., 2001, 58, 1781.

84. Ursing C. et al., Eur. J. Clin. Pharmacol., 2005, 61 (3), 197.

85. Von Bahr C. et al., Eur. J. Clin. Pharmacol., 2000, 56, 123.

86. Voordouw B.C. et al., J. Clin. Endocrinol. Metab., 1992, 74 (1), 108.

87. Waldenlind E. et al., J. Neurol. Neurosurg. Psychiatry, 1987, 50, 207.

88. Waldenlind E. et al., Cephalalgia, 1994, 14, 199.

89. Werbach M.R., Altern. Ther. Health Med, 2008, 14 (4), 54.

90. Wirtz P.H. et al., J. Pineal Res., 2008, 44 (2), 127.

91. Wirojanan J. et al., J. Clin. Sleep Med., 2009, 5 (2), 145.

92. Yu A.M. et al., Pharmacogenetics, 2003, 13 (3), 173.

93. Zhdanova I.V. et al., Pharmacol. Biochem. Behav., 2000, 67 (1), 131.

94. Zhdanova I.V., Sleep Med. Rev., 2005, 9, 51.

95. Zisapel N., Cell Mol. Neurobiol., 2001, 21, 605.